Theophylline derivative inhibits osteoporosis
AssigneeKaohsiung Medical University
InventorsJwu-Lai Yeh, Ing-Jun Chen
Life of this patent
Estimating the term…
Abstract
The theophylline derivative disclosed in the present invention is characterized by having the pharmaceutical functions of osteoporosis. The theophylline derivative protects against bone resorption and inflammatory mediator infiltration.
Claims5
A method of treating a bone disorder, comprising a step of administering to a subject in need thereof an effective amount of a pharmaceutical composition, wherein the pharmaceutical composition contains a pharmaceutically acceptable carrier and an effective amount of 7-[2-[4-(2-chlorophenyl)piperazin-1-yl]ethyl]theophylline, wherein the bone disorder is one selected from a group consisting of an osteoporosis, a knee cartilage injury, an osteoarthritis arthritis, a bone loss and a combination thereof.
Dependencies are inferred from the claim text.